Aoxin Q & M Dental Group (SGX:1D4) clarified its termination of Ong Siew Hwa as CEO of Acumen, citing the recent expiry of Acumen's lab license and the scheduled December closure of its Sengkang facility, which will leave it without revenue-generating operations, according to a Monday filing on the Singapore Exchange.
Acumen's board, with Aoxin's support, is exploring options including tendering for new contracts, reapplying for a lab license, or liquidating assets.
Aoxin's core business in China, spanning dental services and equipment distribution, remains unaffected.
Price (SGD): S$71.69, Change: S$+0.22, Percent Change: +0.31%
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.